Medigen partners with WHO initiative to offer its COVID-19 vaccine technology

Medigen Vaccine Biologics Corp., the manufacturer of the only domestically-made COVID-19 vaccine that has received emergency use authorization in Taiwan, on Tuesday announced its out-licensing agreement with a World Health Organization (WHO) initiative, which would make the vaccine technology available to others.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)